SELLAS Life Sciences Group (SLS) Invested Capital: 2011-2024
Historic Invested Capital for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $15.9 million.
- SELLAS Life Sciences Group's Invested Capital rose 515.26% to $15.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $15.9 million, marking a year-over-year increase of 515.26%. This contributed to the annual value of -$8.0 million for FY2023, which is 264.42% down from last year.
- Per SELLAS Life Sciences Group's latest filing, its Invested Capital stood at $15.9 million for Q3 2024, which was up 445.55% from $2.9 million recorded in Q2 2024.
- In the past 5 years, SELLAS Life Sciences Group's Invested Capital registered a high of $33.4 million during Q2 2021, and its lowest value of -$8.0 million during Q4 2023.
- For the 3-year period, SELLAS Life Sciences Group's Invested Capital averaged around $6.8 million, with its median value being $4.9 million (2022).
- Per our database at Business Quant, SELLAS Life Sciences Group's Invested Capital soared by 783.29% in 2021 and then crashed by 264.42% in 2023.
- Over the past 5 years, SELLAS Life Sciences Group's Invested Capital (Quarterly) stood at $28.0 million in 2020, then declined by 27.23% to $20.3 million in 2021, then slumped by 76.16% to $4.9 million in 2022, then tumbled by 264.42% to -$8.0 million in 2023, then skyrocketed by 515.26% to $15.9 million in 2024.
- Its Invested Capital was $15.9 million in Q3 2024, compared to $2.9 million in Q2 2024 and $9.7 million in Q1 2024.